Download Doherty Institute brochures and capacity statements
Overview of the Doherty Institute
Finding solutions to prevent, treat and cure infectious diseases and understanding the complexities of microbes and the immune system requires innovative approaches and concentrated effort.
This Strategic Plan provides a roadmap for the development of the Doherty Institute over the next five years. The plan sets out the ambition and vision for the Institute supported by a series of strategies and associated tactics which, when pursued to completion, will be expected to deliver the desired institutional culture and outcomes over time.
Doherty Applied Microbial Genomics capacity statement
Doherty Applied Microbial Genomics was established to facilitate research directed towards implementing microbial genomics within public health and clinical microbiology practice in Australia. The centre is funded by The University of Melbourne and houses technology that uses next-generation DNA sequencing, providing unparalleled speed and accuracy to genetically identify and track disease-causing microbes.
Hepatitis B capacity statement
HBV is a major focus for the Peter Doherty Institute for Infection and Immunity (Doherty Institute), with a broad spectrum of activities spanning public health, discovery research and clinical care.
Influenza capacity statement
Influenza is a virus that causes respiratory infection and infects five to 10 per cent of adults globally each year. This is called seasonal influenza and usually occurs in the winter months. Influenza is a major focus for the Doherty Institute, with a broad spectrum of activities spanning surveillance, epidemiology and discovery research.
HIV capacity statement
HIV is a major focus for the Peter Doherty Institute for Infection and Immunity (Doherty Institute), with a broad spectrum of activities spanning discovery research, public health, and clinical care.